The global brachytherapy treatment planning systems market size is expected to reach USD 1.5 billion by 2030, registering a CAGR of 9.3% over the forecast period. The global prevalence of cancer ...

Nucletron, a knowledge-based leader in radiation oncology, today announced the introduction of Oncentra (R) Brachy*, a comprehensive volume-based treatment planning system to optimize cancer ...

Enhanced deep-learning models have the potential to streamline prostate cancer brachytherapy treatment planning, according to investigators.

CHARLOTTE, N.C. , April 16, 2013 /PRNewswire/ — A prostate cancer patient has become the first person in the world to be treated using the latest version of Varian's Vitesse™ real time planning ...

PALO ALTO, Calif. , Jan. 24, 2013 /PRNewswire/ — Varian Medical Systems (NYSE: VAR) has received an FDA 510 (k) clearance for the latest version of its Vitesse™ real time planning for HDR ...

With this in mind, the Birmingham radiation oncology team has, for the past decade, relied on LAP’s RadCalc QA secondary check software – a suite of widely deployed QA tools that provides medical ...

Global Brachytherapy Treatment Planning Systems Market Global Brachytherapy Treatment Planning Systems Market Dublin, March 30, 2022 (GLOBE NEWSWIRE) -- The "Brachytherapy Treatment Planning Systems ...

Nucletron, a knowledge-based leader in radiation oncology, todayannounced the introduction of Oncentra (R) Brachy*, a comprehensivevolume-based treatment planning system to optimize cancer ...